Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants

Dongxiao Sun; Gang Chen; Ryan W Dellinger; Kimberly Duncan; Jia-Long Fang; Philip Lazarus

doi:10.1186/bcr1539

Back

Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants

Journal article

Open access

Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants

Dongxiao Sun, Gang Chen, Ryan W Dellinger, Kimberly Duncan, Jia-Long Fang and Philip Lazarus

Breast cancer research : BCR, Vol.8(4), pp.R50-R50

2006

DOI: https://doi.org/10.1186/bcr1539

Handle:

https://hdl.handle.net/2376/109955

PMCID: PMC1779459

PMID: 16884532

Files and links (1)

url

https://doi.org/10.1186/bcr1539View

Published (Version of record) Open

Metrics

8 Record Views

See more details

Details

Title: Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants
Creators: Dongxiao Sun - Cancer Prevention and Control Program, Division of Population Sciences and Cancer Prevention, Department of Pharmacology, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA
Gang Chen - Cancer Prevention and Control Program, Division of Population Sciences and Cancer Prevention, Department of Health Evaluation Sciences, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA
Ryan W Dellinger - Cancer Prevention and Control Program, Division of Population Sciences and Cancer Prevention, Department of Pharmacology, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA
Kimberly Duncan - Cancer Prevention and Control Program, Division of Population Sciences and Cancer Prevention, Department of Pharmacology, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA
Jia-Long Fang - Cancer Prevention and Control Program, Division of Population Sciences and Cancer Prevention, Department of Pharmacology, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA
Philip Lazarus - Cancer Prevention and Control Program, Division of Population Sciences and Cancer Prevention, Department of Pharmacology, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA
Publication Details: Breast cancer research : BCR, Vol.8(4), pp.R50-R50
Academic Unit: Pharmaceutical Sciences, Department of
Publisher: BioMed Central; London
Identifiers: 99900547371201842
Language: English
Resource Type: Journal article